Operator
Greetings, and welcome to the Global Blood Therapeutics conference call. [Operator instructions] I would now like to turn the call over to Steven Immergut. Please, go ahead.
Steven Immergut --
Senior Vice President, Head of Corporate Communications and Investor Relations
Thank you, and welcome to GBT's conference call to discuss the Company's financial results for the first quarter of 2021 and to provide a business update. I'm Steven Immergut, head of communications and investor relations. Joining me on the call are Dr. Ted Love, our president and CEO, who will provide an update on our progress in the first quarter; Jeff Farrow, our chief financial officer, who will review our financial results; David Johnson, or DJ, our chief commercial officer, will give an update on the Oxbryta launch. Ted will then introduce Dr.
Operator
Good day, and thank you for standing by. Welcome to the Sangamo First Quarter 2021 Teleconference Call. [Operator Instructions].
I would now like to hand the conference over to your speaker today, Aron Feingold, Head of Corporate Communications. Please go ahead.
Aron Feingold --
Head of Corporate Communications
Good afternoon, and thank you for joining us today. With me this afternoon on this call are several members of the Sangamo executive leadership team, including Sandy Macrae, Chief Executive Officer; Mark McClung, Chief Business Officer; Jason Fontenot, Chief Scientific Officer; Rob Schott, Head of Development; and Bettina Cockroft, Chief Medical Officer. Slides from our corporate presentation can be found on our website, sangamo.com, under the Investors and Media section on the Events and Presentations page.